Effects of exogenous somatotropin during early gestation on maternal performance, fetal growth, and compositional traits in pigs

The objective of this study was to determine the effects of maternal treatment with porcine somatotropin (pST) during early gestation on embryonic survival, fetal development, and internal environment for fetal growth. Sixty-two crossbred gilts received daily injections of either 3 mL of a placebo (control, n = 31) or 6 mg of pST (n = 31) from d 10 to 27 of gestation. Representative gilts were slaughtered on d 28, 37, and 62 of gestation. The remaining gilts were allowed to farrow. It was found that embryonic survival was not influenced by pST treatment (P > 0.10). However, pST affected the growth and composition of the maternal (endometrium) and fetal (chorion) parts of the placenta. Thus, endometrial RNA concentration tended to be increased by pST at d 37 (P = 0.15), and it was increased at d 62 (P < 0.05) of gestation, which is indicative of increased capacity for protein synthesis. At birth, placental chorion weight (P < 0.10) and contents of DM and protein (P < 0.05) were increased due to pST treatment, but no effects were detectable up to d 62 of gestation. Maternal pST treatment was effective at increasing nutrient supply to the embryo as suggested from elevated glucose concentrations in amniotic and allantoic fluids (P < 0.05) at d 28 of gestation. With regard to prenatal growth, embryonic DNA concentration was slightly elevated at d 28 (P < 0.10), but pST did not induce any changes in average embryonic, fetal, or neonatal weights. However, within litters, the birth weights of piglets in the 25% lowest weight group (LW) were increased by pST treatment vs control LW pigs (1,241+/-55 vs 1,099+/-59 g, P < 0.10). Thirty-eight neonates from 15 litters divided among the three weight groups were examined for body composition. The weight of the intestinal tract was increased above average after maternal pST treatment (P < 0.01). Additionally, the amounts of tissues such as bone (P = 0.12) and s.c. fat (P = 0.06), and of protein, fat (P = 0.10), and ash (P < 0.05) were increased, whereas the relative body composition remained unchanged by pST (P > 0.10). On average, muscle protein concentration was elevated due to pST (P < 0.01), and, in LW piglets, plasma IGF-I concentration was increased (P < 0.10). The results suggest that maternal somatotropin is a critical factor in early pregnancy capable of influencing placental nutrient transfer and placental growth. It thereby selectively improves the growth conditions for the smaller littermates.     

Effect of sex and exogenous porcine somatotropin on longissimus muscle fiber characteristics of growing pigs

Thirty-seven pigs with an initial live weight of 60 kg were used to investigate the effects of daily exogenous porcine somatotropin (pST) administration at two dose levels (0 and 100 micrograms.kg-1.d-1) for a 31-d period on muscle fiber characteristics and meat tenderness of boars, gilts and barrows. Excipient boars and gilts had more alpha W and fewer alpha R fibers than did those receiving pST. The percentage of muscle fiber type for barrows was not affected by pST treatment. The administration of pST resulted in an increase in muscle fiber size for all three fiber types in all three sexes, but these changes were of greater magnitude in barrows (31.8%) and gilts (27.8%) than in boars (9.3%). Somatotropin negated the intrinsic sex effect differences in fiber area of the pigs. There was no difference in tenderness among excipient boars, barrows and gilts; however, with the inclusion of pST, shear force decreased in boars and gilts and increased in barrows. A high proportion of the pST-treated pigs contained giant fibers in the longissimus muscle. Furthermore, a small proportion of the pST-treated pigs exhibited pale, soft, exudative muscle. Whether the giant fiber anomalies occurred through increased muscle activity or from fibers undergoing degenerative changes was not determined.     

Exogenous somatotropin alters IGF axis in porcine endometrium and placenta

The aim of this study was to examine whether exogenous somatotropin (ST) can alter the insulin-like growth factor (IGF) axis in the porcine epitheliochorial placenta. Crossbred gilts were injected either 6 mg of recombinant porcine ST or vehicle from days 10 to 27 after artificial insemination (term day 116). Control and ST-treated gilts were euthanized on day 28 (8 control/5 treated), day 37 (4 control/6 treated), and day 62 (4 control/6 treated) of gestation. Endometrium and placental tissue samples were collected and subjected to mRNA analyses. In control gilts, somatotropin receptor (STR) and IGF-I mRNA abundance in the endometrium decreased with gestation. Conversely, the amounts of IGF-II mRNA and of IGF binding protein (BP)-2 and -3 mRNA, which were analyzed in endometrium and placental chorion, increased with gestation. The endometrium contained less IGF-II mRNA but more IGFBP-2 and-3 mRNA than the placental chorion. In response to pST treatment, the amounts of endometrial STR and IGF-I mRNA were lower at days 28 and 37, but higher at day 62 of gestation. The content of IGF-II mRNA was higher in the endometrium of pST-treated than control gilts on day 37. The amount of IGFBP-2 mRNA was increased on day 37 in endometrium and placenta of pST-treated gilts, whereas no changes in IGFBP-3 mRNA were observed. The IGF-II/IGFBP-2 ratio was higher in the placenta in response to pST on day 28 of gestation. Results show that pST treatment of pregnant gilts during early gestation alters IGF axis in maternal and fetal placental tissues and suggest pST may exert an effect on fetal growth by altering the relative amount of IGFBPs and IGFs at the fetal-maternal interface.     

Effects of exogenous porcine somatotropin administration between 30 and 60 kilograms on longissimus muscle fiber morphology and meat tenderness of pigs grown to 90 kilograms

Twenty-four barrows were used to investigate the effects of exogenous porcine somatotropin (pST) administration (0 and 100 micrograms.kg-1.d-1) between 30 and 60 kg on longissimus muscle morphology and meat tenderness of pigs grown to 90 kg. Administration of pST was by daily i.m. injection. Pigs were fed a fortified diet in restricted amounts between 30 and 60 kg and had ad libitum access to this diet from 60 to 90 kg. Excipient pigs had fewer alpha R fibers and more alpha W fibers than pST-treated pigs (P less than .05). Administration of pST increased (P less than .05) muscle fiber area for all three fiber types at both the 60 kg (34%) and 90 kg (29%) slaughter weights. Furthermore, pST administration increased shear-force (30% at 60 kg; 19% at 90 kg) of the longissimus muscle, indicating that pST administration reduced meat tenderness. All the pST-treated pigs exhibited the "giant fiber syndrome" and a high proportion (62%) of pST-treated pigs exhibited pale, soft, exudative muscle. Whether the giant fiber anomaly resulted from increased muscle protein accretion rate or fiber degeneration is unknown. Results indicated that the stimulatory effects of pST on muscle growth are sustained following cessation of hormone treatment. However, the incidence of pale, soft, exudative muscle in 62% of the pST-treated pigs indicates that pST potentially has undesirable side effects.     

Dose-response relationships between porcine somatotropin, muscle composition, muscle fiber characteristics and pork quality

The dose-dependent effects of porcine somatotropin (pST) on cellular aspects of skeletal muscle growth, muscle composition and measures of pork quality were investigated in growing barrows and gilts. Eighty crossbred pigs weighing 46 kg were assigned randomly to receive daily subcutaneous injections of 0, 30, 60, 120 or 200 micrograms pST/kg BW until they weighed 100 kg. Semitendinosus muscle weights were increased with pST dose (linear, P less than .001) by 21%. Percentage of type I and type II muscle fibers was not changed with pST, but cross-sectional area of type I and type II fibers was increased in parallel with muscle weight. Percentage of moisture increased (P less than .01) and percentage of lipid decreased (P less than .01) as pST dose increased. The pH of the longissimus 24 h postmortem increased (P less than .01) .1 to .2 units with increasing pST dose, but subjective evaluation for color, firmness and wateriness of the longissimus indicated no discernible treatment effect. Gardner color difference meter "Rd" and "A" values decreased (P less than .01) with a pST dose of 60 micrograms/kg or more, signifying a slightly darker and less red color, respectively, of the longissimus muscle. Weight loss of loin chops 2.54 cm thick cooked to 71 degrees C (20.3% to 23.7%) and shear force of cores 1.27 cm in diameter (2.89 to 3.76 kg) were not related to pST treatment or dose.(ABSTRACT TRUNCATED AT 250 WORDS)     

Efficacy of chromium picolinate on performance and tissue accretion in pigs with different lean gain potential.

We conducted two experiments to determine whether the efficacy of chromium picolinate (CrP) on growth performance, carcass composition, and tissue accretion rates is dependent on the lean gain potential of the pigs. In Exp. 1, 40 barrows (20 from each of two genetic backgrounds; two pigs per pen, five pens per treatment) were fed a fortified, corn-soybean meal basal diet (.95% lysine from 19 to 55 kg BW; .80% lysine from 55 to 109 kg BW) without or with 200 microg/kg of Cr from CrP. The addition of Cr had no effect on performance, carcass measurements, or accretion rates of carcass protein or lipid, regardless of the lean gain potential of the pigs. In Exp. 2, 60 group-penned pigs (three pigs per pen; five pens per treatment) were fed a fortified, corn-soybean meal basal diet without or with 200 microg/kg of Cr from CrP from 21 to 104 kg BW. Within the dietary Cr treatments, half of the pigs received daily injections of 3 mg of porcine somatotropin (pST) from 54 to 104 kg BW. The pST administration resulted in faster growth rates (P < .007), improved feed efficiency (P < .001), increased longissimus area (P < .001), and decreased 10th-rib backfat (P < .001). Administration of pST also increased the percentage and accretion rate of carcass protein (P < .001) and decreased the percentage and accretion rate of carcass lipid (P < .001). The addition of CrP to the diet had no effect on any variable measured in either the untreated or pST-treated pigs. In these studies, Cr was ineffective at altering the composition of the carcass and its effects were not dependent on the pig's potential for lean gain.     

Effects of porcine somatotropin administration on the responses to dietary lysine and a near-ideal blend of amino acids for growing pigs

Two experiments were conducted to assess the effects of porcine ST (pST) on the responses to a near-ideal blend of AA for pigs from 22 to 60 kg BW. Eighty Hampshire × Yorkshire gilts (40 gilts/experiment) were individually penned and assigned to a 4 × 2 factorial arrangement of treatments, consisting of 4 diets with and without pST injection. A fortified corn-soybean meal basal diet was formulated to contain 1.50% total Lys and Thr, Met, and Trp were added to obtain a near-ideal blend of these AA relative to Lys. In 3 additional diets, Lys was reduced to 1.25%, 1.00%, or 0.75% by diluting the basal diet with cornstarch, cellulose, and sand, such that the diets also contained the same ratios of AA. Pigs that received pST were administered a daily intramuscular injection of 2 mg of pST. Data from the 2 experiments were pooled. Administration of pST increased ADG (P < 0.01), G:F (P < 0.01), and LM area (P < 0.01), and decreased ADFI (P < 0.03), last rib backfat (P < 0.01), and 10th rib backfat (P < 0.01). Also, estimated carcass muscle and calculated lean gain increased (P < 0.01) in pST-treated pigs. Administration of pST also increased (P < 0.01) the percentage, total gain and accretion rate of water, protein, and ash in the carcass, and decreased (P < 0.01) the percentage, total gain, and accretion rate of carcass fat. Growth rate, G:F, and carcass traits improved (P < 0.01), percentage of carcass proteinand water increased (P < 0.01), and carcass fat percentage decreased (P < 0.01) with increasing dietary Lys. The percentage, total gain, and accretion rate of carcass protein increased to a greater extent in pST-treated pigs than in untreated pigs, resulting in a pST × Lys interaction (P < 0.05). The results indicated that pST improves performance, leanness, and protein accretion in pigs from 22 to 60 kg BW, and that these responses to dietary Lys and a near-ideal blend of AA is greater in growing pigs treated with pST than untreated pigs.     

Maternal low-dose porcine somatotropin treatment in late gestation increases progeny weight at birth and weaning in sows but not in gilts

Birth weight positively predicts postnatal growth and performance in pigs and can be increased by sustained maternal porcine ST (pST) treatment from d 25 to 100 of pregnancy (term ～115 d). The objective of this study was to test whether a shorter period of maternal pST treatment in late pregnancy (d 75 to 100) could also increase birth and weaning weights of progeny under commercial conditions. Gilts (parity 0) and sows (parities 2 and 3) were not injected (controls) or injected daily with pST (gilts: 2.5 mg?d(-1), sows: 4.0 mg?d(-1), both ～13 to 14 μg?kg(-1)?d(-1)) from d 75 to 100 of pregnancy. Litter size and BW were recorded at birth and weaning, and dams were followed through the subsequent mating and pregnancy. Maternal pST injections from d 75 to 100 increased litter average progeny weight at birth (+96 g, P = 0.034) and weaning (+430 g, P = 0.038) in sows, but had no effect on progeny weight in gilts (each P > 0.5). Maternal pST treatment did not affect numbers of live-born piglets and increased numbers of stillborn piglets in sows only (+0.4 pigs/litter, P = 0.034). Maternal pST treatment did not affect subsequent reproduction of dams. Together with our previous data, these results suggest that sustained increases in maternal pST are required to increase fetal and postnatal growth in gilt progeny, but that increasing maternal pST in late pregnancy may only be an effective strategy to increase fetal and possibly postnatal growth in sow progeny.     

The effect of porcine somatotropin supplementation in pigs on the lipid profile of subcutaneous and intermuscular adipose tissue and longissimus muscle.

The effect of porcine somatotropin (pST) on the lipid profiles of adipose tissue and muscle was investigated. Sixteen crossbred barrows were injected daily with either 3 mg of pST or a placebo. After slaughter, total lipid and fatty acid composition of raw subcutaneous (SC) adipose and intermuscular (IM) adipose tissue and longissimus muscle were determined. The SC adipose tissue from pST-treated pigs had a 7.5% decrease in total lipid content; specific fatty acids 16:0, 18:0, and 18:1(n-9)c decreased most. The IM fat from pST-treated pigs had lower levels of 16:0 and 20:0. There was no effect of pST treatment on the lipid profile of the longissimus muscle. The data suggest that pST treatment produces small but significant changes in the saturated fatty acid content of adipose tissue in pigs.     

Effect of early gestation feeding, birth weight, and gender of progeny on muscle fiber characteristics of pigs at slaughter

Maternal nutrition and progeny birth weight affect muscle fiber development in the pig, thereby influencing early postnatal growth rate. The objective of the study was to determine the extent to which growth, morphometric characteristics, and area and distribution of slow-oxidative (SO), fast oxidative-glycolytic (FOG), and fast glycolytic (FG) fibers of three muscles (LM = longissimus muscle; RF = rectus femoris; ST = semitendinosus) of slaughter pigs were affected by DE intake level during the first 50 d of gestation. Multiparous Swiss Large White sows were assigned randomly to one of three energy intake treatments: 1) fed 2.8 kg/d of a standard diet (STD; n = 6) containing 10.7 MJ DE/kg; 2) fed 2.8 kg/d of a low-energy diet (LE; n = 5) containing 6.6 MJ DE/kg; or 3) fed 4.0 kg/d of a standard diet (HE; n = 5) containing 10.7 MJ DE/kg (as-fed basis). Sows were subjected to energy intake treatments for the first 50 d of gestation; however, from d 51 to parturition, sows received 2.8 kg/d of the standard diet, and the amount of feed offered each sow during lactation was adjusted according to the litter size. Sows farrowed normally and pig birth weights were recorded. Based on birth weight, the two lightest (1.27 kg; Lt) and two heaviest (1.76 kg; Hvy) barrows and gilts from the 16 litters (n = 64) were selected at weaning and were offered a fixed amount of feed (170 g x BW(0.569)/d) from 25 to 105 kg BW. Regardless of the birth weight, progeny from HE sows grew slower (P < 0.05) during lactation and the growing-finishing period, had a lower (P < 0.05) gain-to-feed ratios, and had higher (P < 0.05) percentages of adipose tissue than pigs born from LE sows. The ST was shorter (P = 0.03) in Lt than in Hvy pigs, and the ST of gilts was heavier (P = 0.01) and had a larger (P = 0.01) girth than the ST of barrows. Overall mean fiber area tended to be larger (P < or = 0.11) in the LM and light portion of the ST of Lt than in Hvy pigs, and was larger (P = 0.03) in the ST of gilts than barrows. The ST of progeny from LE sows had fewer (P < 0.10) FG fibers, which was compensated by either more (P < 0.05) FOG in the light portion of the ST, or more (P < 0.10) SO fibers in the dark portion, and these differences were more pronounced in Lt pigs than in Hvy pigs. Overall, maternal feeding regimen affected muscle fiber type distribution, whereas birth weight and gender affected muscle fiber area.     

Recombinant porcine somatotropin for sows during late gestation and throughout lactation.

Two experiments were conducted to evaluate whether administration of recombinant porcine somatotropin (pST) to sows (Hampshire-Yorkshire) enhanced lactational performance. In Exp. 1, sows (n = 84) were fed a corn-soybean meal diet (17.8% CP), or a similar diet with 8% added fat, from d 108 of gestation to d 28 of lactation. Half of the sows fed each diet were injected with 6 mg/d of pST from d 108 of gestation to d 24 of lactation. Diets were fed at 2.27 kg/d from d 108 of gestation until farrowing and then were self-fed during lactation. By d 3 of lactation, litter size was standardized at 8 to 10 pigs per litter. Treating sows with pST resulted in a 10-fold increase (P less than .001) in serum somatotropin at 4 h postinjection. Serum glucose was increased (P less than .01) and serum triglycerides, creatinine, and urea N were decreased (P less than .01) by pST. During the summer, apparent heat stress occurred in pST-treated sows, resulting in 14 deaths. Most (10) of the deaths occurred just before, during, or shortly after farrowing. Fewer (P less than .08) deaths occurred when pST-treated sows were fed the diet with added fat. Sows treated with pST consumed less feed (P less than .10) and lost more backfat (P less than .10) during lactation than controls. Increasing the dietary fat did not prevent these changes. Weaning weights of pigs and milk yield of sows (estimated by deuterium oxide dilution) were not affected by pST treatment. In Exp. 2, sows (n = 42) were injected weekly with 0 or 70 mg of pST on d 3, 10, 17, and 24 of lactation. Litters were standardized by d 3 at 8 to 10 pigs, and sows were fed the same control (low fat) diet as in Exp. 1. Sows treated with pST consumed less feed and lost more weight and backfat during lactation than untreated sows. Litter size, average pig weaning weights, and milk yield were not influenced by pST treatment. These data indicate that a 6-mg daily injection of pST from 6 d prepartum to d 24 of lactation or a 70-mg weekly injection of pST from 3 d postpartum to d 24 of lactation does not increase milk production in lactating sows.     

Effect of recombinant porcine somatotropin on energy and protein utilization by growing pigs: interaction with capacity for lean tissue growth.

Three litters of four pigs from each of four different groups were used to evaluate the effect of porcine somatotropin (pST) on growth performance, body gain composition, energy and N metabolism, and in vitro cytochrome oxydase (final enzyme of the respiratory chain) activity of tissues. The four groups included boars from a synthetic line (SG1) or the Large White breed (SG2) and barrows from the Large White breed (SG3) or crossbred between Large White and Meishan breeds (SG4). Inherent capacity for daily lean tissue growth (LTG) decreased from SG1 to SG4. Within a litter, one pig was slaughtered and dissected at the beginning of the experiment (55 kg BW) and the three others were fed the same daily supply of protein and amino acids (26 g of lysine/d) but relative daily energy levels were either 113 (without pST: E1/0), 100 (3 mg of pST/d: E2/pST) or 87 (3 mg of pST/d: E3/pST). The 100 energy level corresponded to the ad libitum intake of E2/pST pigs. Two energy and N balances were carried out in respiration chambers during the experimental period. Pigs were slaughtered and dissected at approximately 95 kg BW and composition of gain was estimated using the comparative slaughter technique. In E1/0 pigs, daily BW, lean, and N gain were affected (P less than .01) by group; 566, 471, 374, and 315 g/d of lean tissue gain in SG1, SG2, SG3, and SG4 pigs, respectively. At high ME intake (E2/pST vs E1/0), pST increased daily BW (+14%), lean (+27%), or N (+26%) gain and reduced adipose tissue (-50%) gain, but the pST effect was inversely related to LTG: for N, the improvement was 2.8, 7.1, 7.0, and 11.1 g/d in SG1, SG2, SG3, and SG4 groups, respectively. Energy restriction (E3/pST vs E2/pST) reduced (P less than .001) adipose tissue gain in all groups but did not affect lean tissue or N gains in SG1, SG2, and SG3 pigs. In the pST-treated pigs of the SG4 group, the lean tissue or N gains were reduced (P less than .01) by energy restriction. Energy restriction combined with pST treatment (E3/pST) led to negligible amounts of fat deposited (40 g/d for SG1 + SG2 + SG3 pigs) and a gain:feed ratio higher than 500 g/kg (580 in SG1 pigs). The increased heat production measured in pST-treated pigs was due to its maintenance component: 275 vs 257 kcal of ME.kg BW-.60.d-1 (P less than .01).(ABSTRACT TRUNCATED AT 400 WORDS)     

Performance, plasma hormones, histochemical and biochemical muscle traits, and meat quality of pigs administered exogenous somatotropin between 30 or 60 kilograms and 100 kilograms body weight.

Forty-five Large White barrows were injected daily i.m. with either excipient from 30 to 100 kg BW (CTRL), excipient from 30 to 60 and porcine somatotropin (pST; 100 micrograms/kg BW) from 60 to 100 kg BW (pST-60), or pST (100 micrograms/kg BW) from 30 to 100 kg BW (pST-30). Somatotropin accelerated overall growth rate (+4 and +9% for pST-60 and pST-30, respectively), increased longissimus (+10.3 and +14.7%) and semitendinosus (+17 and +13%) muscle weights, and decreased backfat (-49 and -58%) and leaf fat (-49 and -53%) weights. The administration of pST resulted in a similar increase in muscle fiber size for all fiber types in both longissimus (LM) and semispinalis (SS) muscles (+21%). Somatotropin had otherwise little effect on muscle fiber types and biochemical traits of LM, whereas dramatic changes were observed in SS. The relative area occupied by Type IIB fibers was increased (+22 and +29%) and that of Type I fibers was decreased (-10 and -15%). In pST-30 animals, myosin ATPase activity (+15%) and native myosin fast isoform proportion (+10%) were augmented, and energy metabolism was more glycolytic (lactate dehydrogenase: +25%) and less oxidative (citrate synthase: -13%; beta-hydroxyacyl-CoA dehydrogenase: -21%). Compared to CTRL animals, administration of pST increased muscle water concentration (LM: +.8 and +1.1%: SS: +3.3 and +3.3%) and decreased intramuscular fat (LM: -29 and -27%; SS: -39 and -50%). The pH measured 45 min and 24 h postmortem, glycogen content, reflectance, and index of light diffusion were mostly not affected by pST treatment. In conclusion, pST had a very favorable effect on growth performance without any important effect on meat quality traits except for the reduction in intramuscular lipid content. The results indicated that the effects of pST on muscular histochemical and biochemical characteristics were different in LM and SS muscles.     

Interrelationships between dietary lysine, sex, and porcine somatotropin administration on growth performance and protein deposition in pigs between 80 and 120 kg live weight

Sixty male and 60 female crossbred pigs were allocated to an experiment to investigate the effects of porcine somatotropin (pST) administration (0 or 6 mg/d) and dietary lysine content on growth performance, tissue deposition, and carcass characteristics over the live weight range of 80 to 120 kg. Pigs receiving pST were given diets containing 6.9, 7.8, 8.8, 9.7, 10.6, or 11.5 g lysine/kg, whereas control pigs received diets containing 4.8, 5.8, 6.9, 7.8, 8.8 or 9.7 g lysine/kg. These dietary levels ranged from 0.40 to 0.70 g available lysine/MJ of DE for pST-treated pigs and from 0.28 to 0.58 g available lysine/MJ of DE for control pigs. Pigs were individually housed in pens, and there were five replicates of each treatment. All diets contained 14.5 MJ of DE/kg and were offered for ad libitum consumption to pigs between 80 and 120 kg live weight. Growth rate increased exponentially and food conversion ratio (FCR) decreased exponentially with increasing levels of lysine. In addition, there was a significant sex x pST interaction such that pST reduced the sex difference in FCR. Growth rate was faster in boars than in gilts and was increased by pST at the higher levels of dietary lysine. Similarly, FCR was lower for boars than for gilts and was decreased by pST at the higher dietary lysine levels. The optimum growth rate and FCR were defined as the lysine level at which growth rate and FCR were 95% and 105%, respectively, of the lysine plateau. The optimum growth rate and FCR were achieved at similar dietary lysine contents and were approximately 0.35 and 0.52 g available lysine/MJ of DE for control and pST-treated pigs, respectively. Protein deposition in the carcass increased exponentially with increasing dietary lysine level, was higher in boars than in gilts, and was increased by pST at the higher dietary lysine contents. Sex had no effect on dietary lysine required to maximize protein deposition. The dietary lysine contents required to ensure 95% of plateau protein deposition of 104 and 153 g/d were 0.39 and 0.55 g available lysine/MJ of DE for control and pST-treated pigs, respectively. The increase in lysine requirement with pST seems to be commensurate with the increase in protein deposition.     

The performance and carcass composition responses of finishing swine to a range of porcine somatotropin doses in a 1-week delivery system.

Four experiments using 580 barrows and 580 gilts (Study 1) and seven experiments using 500 barrows and 500 gilts (Study 2) were conducted at various geographical locations in the United States to determine the dose response of a pelleted form of porcine somatotropin (pST) relative to ADG, feed/gain (F/G), and percentage of carcass protein. Average initial weights for Studies 1 and 2 were 67.6 and 72.6 kg, respectively, and four pigs/pen were slaughtered when they achieved weights of 106.5 to 111.0 kg. In Study 1, pigs were implanted subcutaneously with pelleted pST doses of 0, 12, 24, 36, or 48 mg/wk and self-fed a corn-soybean meal diet containing 13.75% CP. Study 2 included two control groups self-fed a diet containing either 13.75 or 17% CP with added lysine. The pST-treated pigs were administered 12, 24, or 36 mg/wk, and all were offered the 17% CP diet. The pST treatments in Study 1 resulted in a linear reduction (P less than .05) in average daily feed intake (ADFI) and a quadratic (P less than .05) improvement in F/G and percentage of carcass protein. The pST treatments in Study 2 resulted in a linear reduction in ADFI (P less than .05), a linear improvement in F/G, and a quadratic increase in the percentage of carcass protein (P less than .05). Average daily gain was not affected in either study with this form of pST. The greatest increase in efficiency of lean gain was observed with the 36-mg dose for both Study 1 (9.4%) and Study 2 (10.8%). In Study 1, the force required to shear cores of the longissimus muscle was increased linearly with pST treatment (P less than .05). There was a similar linear increase in Study 2 with pST treatment (P less than .05); however, there was also an effect of sex (P less than .05) on shear force (gilts greater than barrows) that was similar in magnitude to that observed for pST treatment. Differences in sensory evaluation because of pST were minor and of the same magnitude as those observed between barrows and gilts. It was therefore concluded that weekly administration of pST improved F/G and percentage of carcass protein with no detrimental effects on palatability of cooked lean pork.     

Increased sow nutrition during midgestation affects muscle fiber development and meat quality, with no consequences on growth performance

Pregnant sow nutrition has potential effects on the muscle fiber development of progeny in utero. A total of 199 Landrace x Large White sows from parities 0 to 6 and their offspring were used to evaluate the effects of increasing the feeding amount during midpregnancy on the muscle tissue, growth performance, and meat quality of the progeny. The experiment was divided into 2 study replicates, and in each replicate, sows were assigned to 1 of the 2 treatments: 1) sows in the control group (C sows) were fed 2.5 to 3.0 kg/d (feed: 12.1 MJ of ME/kg and 0.62% lysine) throughout gestation; and 2) sows in the high group (H sows) received an extra feed allowance of 1.5 kg/d for gilts and 2.0 kg/d for multiparous sows above the C amount from d 45 to 85 of gestation (period of secondary muscle fiber formation). Sow backfat was recorded on d 40 and 85 of gestation. Sow performance (litter size and piglet BW) at farrowing and on d 18 of lactation was measured. At weaning, pigs were divided into 5 BW groups/treatment, and progeny growth performance was measured during the nursery (n = 958) and the growing-finishing (n = 636) periods. At slaughter, carcass and meat quality traits (lean content, main cut weight, pH, Minolta color, and drip loss) were recorded from the second lightest group at weaning (BW group 4; n = 90), and samples from the longissimus thoracis muscle were taken to study muscle fiber characteristics (n = 70). The extra nutrition from d 45 to 85 of gestation did not lead to differences in litter size or piglet BW at farrowing and on d 18 of lactation. Pigs born to H mothers had fewer muscle fibers and fewer estimated primary and secondary fibers than did pigs born to C mothers (P < 0.05). However, postnatal growth performance was not consistently affected by the maternal treatment. The smaller number of muscle fibers found in the H group of pigs was associated with fewer type IIB fibers (P < 0.05) with greater cross-sectional areas (P < 0.10), which might be related to the significantly greater meat pH at 24 h postmortem and the smaller L* (lightness) values recorded in the H group of pigs. Results from the present study confirm the existence of effects of maternal nutrition on fetal development, at least in terms of muscle tissue development and meat quality, although with no beneficial effects were found for the postnatal growth performance of the progeny.     

Manipulation of growth in pigs through treatment of the neonate with clenbuterol and somatotropin

Neonatal pigs were treated with lipolytic agents to determine whether this would cause a long-term decrease in their ability to deposit fat, with a consequent increase in muscle growth and feed efficiency. Groups of 25 female piglets were given clenbuterol (100 microg/kg BW), porcine somatotropin (pST; 100 microg/kg BW), pST plus clenbuterol, or saline injections from 3 d to 40 d of age. Five piglets from each group were then slaughtered to determine body composition. Clenbuterol and pST both increased ADG up to weaning when given separately (24%, P < 0.05; 20%, P < 0.1 respectively) but did not reduce fat deposition. In contrast, pigs given clenbuterol plus pST showed no increase in ADG and a 41% reduction in carcass fat (P < 0.05). Clenbuterol caused a marked decrease in beta2-adrenoceptor density in porcine adipose tissue (P < 0.001) and skeletal muscle (P < 0.01). This effect was attenuated by concurrent pST treatment, which helps to explain the synergistic effect of these drugs on fat deposition. Once the drugs were withdrawn at 40 d, the anabolic effect of pST gradually disappeared, so that the live weight of pST-treated and control pigs was identical at 168 d. Clenbuterol withdrawal caused the rapid loss of extra weight gained, plus an additional 4 to 5 kg live weight that was never recovered. During the 4-wk finishing period there was an increase in feed intake in pigs that had previously undergone treatment with pST (23%, P < 0.1), with no increase in ADG, and so feed efficiency was impaired (P < 0.05). Pigs that were treated with pST plus clenbuterol showed no marked increase in feed intake during this period. Carcasses from clenbuterol-treated pigs tended to be leaner at 168 d, but there was no long-term effect of pST or the combined treatment on carcass composition. Overall, the treatment of neonatal pigs with repartitioning agents was counter-productive, due to the withdrawal effects of the beta-adrenefgic agonist and the delayed long-term effect of pST on feed intake.     

Temporal response of circulating metabolites and hormones during somatotropin treatment of growing pigs.

Temporal responses in the circulating concentrations of a number of intermediary metabolites and metabolic hormones were studied in chronically catheterized barrows (n = 4 per treatment) after either daily i.m. injection of porcine somatotropin (pST, 120 micrograms/kg of BW) or excipient. Blood sampling (every 1 or 2 h) began 24 h before the first injection (d 0) and continued until the end of d 2. Sampling was repeated on d 7 of treatment. Feed intake declined by d 3 in the pST-treated pigs and was 31% lower by d 7 of treatment (P less than .05). Blood glucose and plasma insulin concentrations began to increase about 3 h after the first pST injection, almost returning to preinjection levels before the next injection. By the end of d 2, circulating levels of glucose and insulin were higher in pST-treated pigs than in the controls. A temporal pattern of hyperglycemia and hyperinsulinemia was observed postinjection on each day of treatment. Although pST treatment did not chronically increase basal plasma concentrations of nonesterified fatty acids and glycerol, both metabolites exhibited transient postinjection elevations, the magnitudes of which were augmented by duration of treatment. Plasma urea nitrogen concentrations began to decrease within a few hours after the first pST injection and by d 7 were 70% (P less than .01) lower in the pST-treated pigs. A model is presented implicating pST-induced decreases in peripheral tissue insulin sensitivity and(or) responsiveness in the observed temporal responses in lipid and carbohydrate metabolism.     

Long-term, but not short-term, treatment with somatotropin during pregnancy in underfed pigs increases the body size of progeny at birth

Treatment of pigs with porcine ST (pST) in early to mid-pregnancy increases body weight and length of their fetuses by mid-pregnancy, but this increased weight may not persist to birth. We investigated the effects of short- (25 d) and long-term (75 d) treatment with pST, and interactions between long-term pST treatment and crude protein content of diet, in restricted-fed gilts. In both experiments, Large White x Landrace gilts were bred at first estrus to Large White x Duroc boars and allowed to farrow naturally. In the first experiment, gilts were fed 1.8 kg/d of a diet containing 13.5 MJ DE/kg of DM and 15.05% CP (as-fed basis) throughout pregnancy, and were injected daily with 0, 2, or 4 mg pST from d 25 to 50 of pregnancy. Maternal treatment with pST from d 25 to 50 of pregnancy did not affect the number of piglets born per litter or progeny size at birth. In the second experiment, gilts were injected daily with 0 or 2 mg of pST and fed 2.2 kg/d of a diet containing 14.5 MJ DE/kg and either (as-fed basis) 16.6% (0.81% lysine) or 22.2% CP (1.16% lysine) from d 25 to 100 of pregnancy. All gilts were then fed 3.0 kg/d of the lower protein diet from d 100 of pregnancy to farrowing. Treatment with 2 mg pST/d from d 25 to 100 of pregnancy increased live weight of all gilts during the treatment period (P = 0.016), but the change in maternal live weight from d 25 to 100 of pregnancy was only increased (P = 0.001) by pST in gilts fed the higher protein diet. Live weight of gilts 1 d after farrowing was increased by pST treatment (P = 0.007), but was not altered by protein content of diet during pregnancy. In gilts fed the lower protein diet, but not in those fed the higher protein diet, pST treatment decreased maternal backfat depth during treatment (P < 0.020) and 1 d after farrowing (P = 0.002). Treatment with pST during pregnancy did not affect the number of piglets born per litter but independently increased body weight by 11.6% (P < 0.001) and length by 3.4% (P = 0.005) of progeny at birth and decreased (P < 0.01) the negative effect of litter size on body weight at birth. We conclude that in feed-restricted gilts, fetal weight gains in response to 25 d of pST treatment before mid-pregnancy are not maintained to term but that treatment with pST during most of pregnancy increases progeny size at birth and reduces maternal constraint of fetal growth.     

Effect of energy and lysine intake in gestation on sow performance

Nutrient intake during gestation has an impact on gestation parameters and subsequent lactation performance. The objectives of this experiment were to determine the impact of feeding two levels of amino acids in gestation on sow BW changes in gestation and lactation, and litter size, and to evaluate a factorial method for determining daily energy requirements. At mating, 419 sows (Camborough 15; Pig Improvement Canada, Acme, AB) were assigned randomly within Parities 1, 2 or 3+ to a gestation diet containing either 0.44% (low lysine) or 0.55% (high lysine) total lysine and 3,100 kcal DE/kg; other indispensable amino acids were adjusted to lysine based on ideal protein ratios. Feed allowance in gestation was determined factorially using estimated DE requirements for maintenance, maternal gain, and conceptus growth. Sows were allowed free access to the lactation diet. Gestation BW gain from d 0 to 110 was affected by parity (61.2, 60.0, and 42.3 kg for Parity 1, 2, and 3+, respectively; P < 0.05) but not (P > 0.10) by gestation lysine level. Sow BW changes from d 0 of lactation to weaning were affected by parity (0.5, 6.8, and 5.8 kg for Parity 1, 2, and 3+, respectively; P < 0.01) and gestation BW gain (P < 0.01), but not by gestation lysine level (5.0 vs 3.8 kg for low and high lysine, respectively; P > 0.10). Total piglets born was affected by parity (11.5, 12.1, and 12.5, for Parity 1, 2, and 3+, respectively; P < 0.01) and increased with increasing sow BW gain (P < 0.05). Total piglets born alive (mean = 11.2) was increased with increasing sow BW gain (P < 0.05). Total litter weight born alive was affected by parity (15.9, 18.6, and 19.4 kg for Parities 1, 2, and 3+, respectively; P < 0.01) and gestation BW gain (P < 0.05). The model used to determine daily energy intake requirements resulted in an average BW gain of 10.6 kg above the targets set by the model. Total lysine intakes greater than 10.6 g/d in gestation did not improve sow productivity. Setting target weight gains in gestation and feeding to meet these targets may not always provide predictable results due to a number of factors that affect the energy requirement in the sow.